German healthcare and materials group Merck KGaA has dropped a surcharge on life sciences sector orders within China ...

EARNINGS FORECAST: Merck's earnings before interest, taxes, depreciation, amortization and one-off items is forecast to come in at 1.51 billion euros, according to the consensus. The company reported ...

The global CRISPR Market, valued at US$2.90 billion in 2024, is forecasted to grow at a robust CAGR of 11.2%, reaching ...

Merck Foundation, the philanthropic arm of Merck KGaA Germany underscored their long-term commitment to build healthcare ...

the philanthropic arm of Merck KGaA Germany underscored their long-term commitment to build healthcare capacity and break infertility stigma in Maldives during their high-level meeting with H.E ...

Metastatic colorectal cancer (mCRC) continues to pose a clinical and commercial challenge, with low 5-year survival rates and limited durable responses to existing therapies. While standard ...

HELSINKI, May 13, 2025 (GLOBE NEWSWIRE) -- TILT Biotherapeutics (Tiltbio), a clinical-stage biotechnology company developing ...

Total cost of revenue was $6.8 million in the first quarter of 2025, a decrease of 5% compared to $7.1 million in the first ...

Germany’s Merck KGaA has joined with UK-based Artios Pharma in a potential multi-billion dollar deal to investigate novel DNA damage response targets in cancer. The principle of DNA damage ...